Alcor Scientific Demonstrates Fully-Automated ESR Analyzers
|
By LabMedica International staff writers Posted on 14 Nov 2023 |

ALCOR Scientific (Smithfield, RI, USA) is demonstrating its innovative diagnostic instrumentation and medical devices for the healthcare industry at MEDICA 2023.
Visitors to the ALCOR booth can take a close look at the iSED ESR Analyzer and the miniiSED ESR Analyzer which provide virtually instantaneous results with a fully automated workflow. ALCOR’s iSED capillary photometry technology is based on syllectometry. Photometric rheology is used to quantify the rouleaux formation, which is the earliest and most critical phase of red blood cell sedimentation. Red blood cells are injected into the iSED analyzers’ flow cell which causes them to disaggregate. The flow cell sensors capture the difference in light transmission over time as the injected red blood cells begin to re-aggregate.
The technical innovation of ALCOR’s ESR analyzers consists of “directly” measuring the aggregation of the red blood cells, whereas the traditional methods “indirectly” measure the aggregation of the red blood cells by recording the length at which the red cells settle in a Westergren tube. Like traditional ESR testing, iSED results are provided in mm/hr. iSED technology is highly correlated to the Westergren method, and test results are available in just 15-20 seconds without the drawbacks and inconvenience of traditional ESR testing.
At MEDICA 2023, ALCOR is also presenting SENTINELplus Enteral Feeding Pump which is an enhanced version of the company’s popular SENTINEL feeding pump. It delivers the same simplicity and reliability as its predecessor in a lighter and smaller package. Its bright LED display allows caregivers to simultaneously and conveniently view the infusion rate and volume delivered from a distance. Additionally, the pump retains the operating history until manually erased, even in the event of power failures or when it is turned off. ALCOR is highlighting its SEDiTROL Quality Controls which are bi-level, human-based, whole-blood external controls used to monitor the performance of the iSED, iSED ELITE, and miniiSED ESR analyzers and testing techniques. SEDiTROL controls are derived from human blood to mimic a patient sample and are processed in the same manner as a patient sample. For efficiency and convenience, the controls are stored at room temperature and can be placed directly into the analyzer.
Related Links:
ALCOR Scientific
Latest Medica 2023 News
- Absology Showcases Latest Advancements in Medical Diagnostics
- Noul Showcases AI-Driven Blood and Cancer Diagnostic Platform
- Oruba Presents State-of-the-Art Self-Operating Uroflowmeters
- Awareness Technology Exhibits Incredibly Flexible ChemWell 2 ELISA and Chemiluminescent Analyzer
- BioVendor Group Demonstrates Unique IVD Platform and Immunoblot Test
- Greiner Bio-One Highlights Magnetic 3D Cell Culture Technology
- Fujirebio Showcases Range of Novel Testing Solutions
- Sentinel Diagnostics Demonstrates New SENTiNAT 200 and STAT-NAT Kits for Infectious Diseases
- DiaSys Showcases High Quality Diagnostic Reagents and System Solutions
- Randox Exhibits Full Range of Molecular Diagnostic Solutions
- Bosch Healthcare Presents Vivalytic Point-of-Care PCR System
- CerTest Presents Innovations Related to VIASURE Products
- Vircell Highlights All-in-One CLIA System and Real Time PCR Kits
- Tianlong Showcases Cutting-Edge Products and Innovative Molecular Diagnostic Solutions
- Getein Biotech Exhibits Advanced POCT Analyzers
- LumiraDx Demonstrates Transformative Tests and Technologies
Channels
Clinical Chemistry
view channel
Electrical Fingerprint of Extracellular Vesicles Could Detect Pancreatic Cancer
Pancreatic cancer is often diagnosed only after it has spread, contributing to a five-year survival rate of 13%. Standard blood-based analyses can struggle to distinguish tumor signals from the background... Read more
Blood Biomarker May Track Bone Metastases in Medullary Thyroid Cancer
Medullary thyroid cancer (MTC) is a rare malignancy that often progresses silently, frequently going undetected until it reaches advanced stages. By the time it spreads to bone, it can produce unusual... Read more
Blood Biomarkers Help Assess Growth Risks During Steroid Treatment in Duchenne Muscular Dystrophy
Children with Duchenne muscular dystrophy (DMD) commonly receive long-term corticosteroids to slow disease progression, but these drugs can impair linear growth and weaken bone. Understanding how specific... Read moreMolecular Diagnostics
view channel
40-Gene Test Validated for High-Risk Squamous Cell Carcinoma
High-risk cutaneous squamous cell carcinoma (SCC) requires accurate stratification to align surveillance and adjuvant therapy with each patient’s risk. Clinicopathologic staging alone may not precisely... Read more
Common Genetic Marker Predicts Faster Motor Decline in Parkinson’s Disease
Parkinson’s disease is a progressive neurodegenerative disorder, but rates of motor decline vary widely among patients, complicating prognosis and clinical trial design. Clinicians have few scalable tools... Read more
Blood Test Helps Clarify Prostate Cancer Risk After Elevated PSA
Prostate cancer screening often begins with prostate-specific antigen (PSA) testing, but elevated results can also occur in benign conditions, creating uncertainty and sometimes leading to invasive procedures.... Read more
Secure Cloud-Connected qPCR System Enables Remote Infectious Disease Surveillance
Rapid infectious disease detection and monitoring require secure, timely access to molecular test data across distributed sites. As point-of-care quantitative PCR (qPCR) expands, remote control, biosurveillance... Read moreHematology
view channel
Borderline Anemia May Carry Higher Risk Than Current Thresholds Suggest
Hemoglobin concentration is among the most frequently ordered blood tests in primary and hospital care. In older adults, both high and low values have been linked to adverse outcomes, including cognitive... Read more
Biomarker-Guided Framework Aims to Guide Mantle Cell Lymphoma Therapy
Mantle cell lymphoma can follow widely variable courses, from indolent disease to rapidly progressive cancer, complicating initial treatment selection. Many therapeutic decisions still rely on patient... Read moreImmunology
view channel
New Cellular Map May Help Predict Crohn’s Disease Course in Children
Crohn’s disease in children is a common and debilitating form of inflammatory bowel disease, marked by chronic intestinal inflammation and limited pediatric-specific treatments. Clinicians must decide... Read more
Temporal Immune Profiling Reveals How Sepsis States Change Over Time
Sepsis is a life-threatening condition in which the immune response to infection becomes dysregulated, leading to rapid organ failure and death. Although antimicrobials and organ support remain standard... Read more
Study Identifies Immune Cells That Drive Harmful Autoantibody Responses in COVID-19
Autoantibodies that mistakenly attack the body’s own tissues have been linked to severe COVID-19, Long COVID, and increased risk of autoimmune disease. However, the origins of these autoantibodies during... Read moreMicrobiology
view channel
Research Strengthens Bundibugyo Virus Outbreak Readiness with Faster Diagnostics
Bundibugyo virus (BDBV), a species of ebolavirus, causes severe hemorrhagic disease and can be difficult to diagnose rapidly during outbreaks. Recent regulatory changes have further complicated swift deployment... Read more
Gut Microbiome Classifier Improves Colorectal Cancer Risk Stratification
Colorectal cancer remains a leading cause of cancer mortality, and current noninvasive screening methods still miss many precancerous lesions. Clinicians therefore need tools that improve risk stratification... Read morePathology
view channel
Hybrid Computational Imaging Method Improves Digital Pathology Resolution
Digital pathology depends on high-resolution whole-slide imaging to capture diagnostically relevant cellular and tissue features, yet conventional methods often force trade-offs between speed, cost, and detail.... Read more
FDA Clearance Expands Digital Pathology Options for Clinical Laboratories
Hamamatsu Photonics K.K. (Hamamatsu, Japan) announced it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the NanoZoomer S20MD and NanoZoomer S540MD slide scanner systems.... Read moreTechnology
view channel
New Multipurpose Centrifuge Combines High Capacity with Sustainable Cooling
Laboratories often need centrifugation that accommodates multiple vessel formats while maintaining controlled temperatures to protect sensitive samples. Intuitive controls and repeatable operation can... Read more
Bacterial Vesicle Expression System Streamlines Production of Cancer Diagnostic Proteins
Recombinant proteins are central to many cancer diagnostics and therapies, but numerous targets remain difficult and costly to produce because they are unstable, toxic to microbial hosts, or require precise folding.... Read moreIndustry
view channel
Sysmex and Cytek Collaboration Expands Access to Advanced Clinical Flow Cytometry
Sysmex Europe SE (Hamburg, Germany) and Cytek Biosciences (Fremont, CA, USA) are partnering across more than a dozen European countries to expand access to advanced clinical flow cytometry.... Read more






.jpg)

